|
Still deciding? Get samples of $ !
Request Sample
|
| Customization: | Available |
|---|---|
| CAS No.: | 22457-89-2 |
| Formula: | C19h23n4o6PS |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Benfotiamine is vitamin B1 fat soluble derivatives, improve the bioavailability of water-soluble vitamin B1 low shortcomings, improve the blood and tissue concentrations of thiamine, so as to improve the curative effect. Benfotiamine is primarily marketed as an antioxidant dietary supplement.
Benfotiamine:N-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)formamide-S-benzoate dihydrogen phosphate
Molecular Structure:
Molecular Formula:C19H23N4O6PS
Molecular Weight:466.45
CAS No.: 22457-89-2
EINECS:245-013-4
| Items | Specification | Result |
| Benfotiamine | 99% | 99.02% |
| Organoleptic | ||
| Appearance | Fine Powder | Conforms |
| Color | White powder | Conforms |
| Odor | Characteristic | Conforms |
| Taste | Characteristic | Conforms |
| Physical Characteristics | ||
| Particle Size | NLT 100% Through 80 mesh | Conforms |
| Loss on Drying | <=12.0% | Conforms |
| Ash (Sulphated Ash) | <=0.5% | Conforms |
| Total Heavy Metals | ≤10ppm | Conforms |
| Microbiological Tests | ||
| Total Plate Count | ≤10000cfu/g | Conforms |
| Total Yeast & Mold | ≤1000cfu/g | Conforms |
| E.Coli | Negative | Negative |
| Salmonella | Negative | Negative |
| Staphylococcus | Negative | Negative |
1.Benfotiamine is used for the prevention and treatment of vitamin B1 deficiency;
2.For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
3.Benfotiamine is used in the treatment of non alcoholic wernicke encephalopathy;
4.To treat beriberi;
5.Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.